In a concerted effort to tackle the growing opioid crisis, U.S. health officials, including the FDA and prominent figures like RFK Jr., are implementing stringent measures to restrict products related to the synthetic opioid 7-OH, often derived from kratom. Complaints from the supplement industry have sparked these actions, leading to recommendations for classifying 7-OH and concentrated kratom as controlled substances. FDA officials are warning consumers about the dangers of opioid-like substances available in convenience stores and gas stations, emphasizing the need for regulation. A press conference hosted by government officials will outline further steps to safeguard public health from these threatening products, as health officials collectively aim to curb what is described as a potential public health crisis.